Label modifier texts

The component has been ordered for an intrauterine transfusion.

The expiry has been reduced to 48 hours post-application of the modifier (eg, washing).

The originating donor sample/donation has been tested for CMV antibody and is negative.

This component has been released without NAT testing being performed, usually due to extenuating circumstances such as machine failure or specific clinical demand.

A disclaimer form will accompany these components.

The originating donor sample/donation has been tested and anti-T was not detected.

The originating donor sample/donation has been tested and is IgA deficient.

The component is from a Le (a-b+) donor and, as such, is suitable for absorption of Lewis antibodies. Suitable for transfusion.

The component has been deemed unsuitable for neonatal use due to the presence of red cell antibodies (low titre only).

It should not be transfused to a neonate.

The originating donor sample/donation or previous testing of donor has had an extended phenotype performed and forms part of a panel of cells reserved for patients with antibodies or where antigen negative blood is otherwise specifically required.

The originating donor sample/donation has low levels of anti-A and anti-B.

This autologous component has tested positive for one or more viral markers but has been released upon request by the patient’s physician.

A disclaimer form will accompany these components.

Notes: NAT: nucleic acid technology; CMV: cytomegalovirus; IUT: intrauterine transfusion